Subaru Kuroda

Subaru Kuroda currently serves as the Director of Clinical Data and Medical Affairs at Eisai Korea, where he leverages over a decade of expertise in biomedicine, precision medicine, and clinical data analysis to advance innovative healthcare solutions. In his role, Subaru oversees complex clinical trial data management processes, ensuring data integrity, regulatory compliance, and the integration of cutting-edge AI and biostatistics techniques to optimize drug development pipelines. His strategic focus on precision medicine applications enables tailored therapeutic approaches, aligning with the evolving landscape of personalized healthcare. Subaru has been instrumental in leading key projects that utilize AI-driven medical data analysis to identify biomarkers, improve patient stratification, and enhance clinical trial efficiency. His deep understanding of regulatory frameworks and international medical affairs allows him to navigate the complexities of global drug development while maintaining rigorous standards for data quality and compliance. With a strong background in genomics and bioinformatics, Subaru applies advanced data analytics to extract actionable insights from large-scale clinical datasets, fostering innovation in targeted therapies. His expertise in integrating AI in healthcare data not only accelerates clinical decision-making but also supports the development of novel treatment paradigms. Subaru’s leadership in bridging clinical research, data science, and medical affairs positions him as a key driver in the adoption of precision medicine strategies within the Korean market and beyond, contributing significantly to Eisai’s mission of delivering meaningful therapeutic advancements.